Examining GBM patient tumors (n = 269) for copy number and gene expression data revealed that ZEB1 deleted tumors demonstrated increased CD133 expression compared to ZEB1 wildtype tumors (Fig. S3b, P = 0.023). This evidence concerns the gene ZEB1 and glioblastoma.